Search results for "vaccination"

showing 10 items of 660 documents

"Kinderkrankheiten" 2002

2002

Vaccinationmedicine.medical_specialtyOtorhinolaryngologyCross-sectional studybusiness.industryFamily medicinemedicinebusinessHNO
researchProduct

From epidemiology to public health decision making: analysis on IMD & vaccination strategy in Italy

2020

Abstract Introduction Invasive Meningococcal Disease (IMD) is one of the most severe vaccine-preventable disease, with high fatality rate and severe sequelae in up to 20% of survivors. MenB, MenC and MenACWY vaccines are available in Italy, but recommendations vary among Italian regions in terms of type of vaccines and targeted age groups. The aim of the study is to describe epidemiology of IMDs in order to provide the best vaccination strategy. Methods IMDs surveillance data in the period 2011-2017 from the Italian National Health Institute were explored. Excel was used to present trend analysis, stratifying by age and serogroups. Results In Italy, during the period 2011-2017, IMDs overall…

Vaccinationmedicine.medical_specialtyPolitical scienceEnvironmental healthPublic healthEpidemiologyPublic Health Environmental and Occupational HealthmedicineDecision making analysisEuropean Journal of Public Health
researchProduct

Intensity of the phenomenon of refusal to subject children to preventive vaccinations in the years 2002-2016 based on analysis of primary health care…

2018

Background. Vaccinations are the most effective method for preventing infectious diseases. Massive implementation of long-term vaccinations strategies has resulted in elimination or a reduced incidence of many infectious diseases. Aim of the study. To evaluate the intensity of the phenomenon of refusal to subject children to preventive vaccinations by attempting to characterize the parental group who refuse to vaccinate their children, determining the type and number of unrealized vaccinations, and identifying the reasons for being unvaccinated. Material and methods. The research material was medical records from the Non-Public Heath Care Unit in Opole. It concerned implementation of the Pr…

Vaccinationmedicine.medical_specialtybusiness.industryFamily medicineMedical recordPhenomenonpublic healthmedicinePrimary health careSubject (documents)businessvaccinationpreventive medicineMedical Science Pulse
researchProduct

How should vaccination services be planned, organized, and managed? Results from a survey on the Italian vaccination services

2019

Background. Quality improvement is an increasingly recognized approach to maximize service effectiveness and minimize costs in public health. However, the Italian law never provided for the institutional accreditation of vaccination services. Furthermore, a recently approved law added six more compulsory vaccinations to the original four, which has led to a considerable increase in vaccination efforts, without any previous resources evaluation. The aim of the study was to investigate structural, organizational and managerial characteristics of the Italian vaccination services, in order to suggest the adoption of adequate quality standards. Study design. A survey involving the representative…

Vaccine coverageImmunization ProgramsImmunization ProgramPerformanceInfant NewbornInfantMandatory ProgramMandatory ProgramsQuality ImprovementStandardManagementVaccination serviceItalyHealth Care SurveyHealth Care SurveysHumansImmunization ScheduleManagement; Performance; Quality assessment; Standard; Vaccination service; Vaccine coverageHumanQuality assessmentAged
researchProduct

The Italian Version of the Adult Vaccine Hesitancy Scale (aVHS) for the Working-Age Population: Cross-Cultural Adaptation, Reliability, and Validity

2022

The adult Vaccine Hesitancy Scale (aVHS) is valid and reliable for evaluating attitudes toward vaccine preventable diseases (VPDs). The aim of the present study was to evaluate the cross-cultural adaptation, reliability, and validity of the Italian version of the aVHS. After cross-cultural adaptation of the aVHS, internal consistency (IC), intra-class correlation (ICC), and content validity (S-CVI) were evaluated through a survey on 160 workers. Results of the ICC were analyzed on questionnaires administered twice at a distance of two months and revealed a satisfactory reproducibility (0.87). The IC of the aVHS was assessed by the Cronbach alpha coefficient test, with a result of 0.94, demo…

Vaccine preventable diseasePharmacologySARS-CoV-2VaccinationImmunologyCOVID-19vaccination; workplace; SARS-CoV-2; vaccine hesitancy; Italy; worker; COVID-19; vaccine preventable diseaseSARS‐CoV‐2Infectious DiseasesItalyCOVID‐19Drug DiscoveryWorkerPharmacology (medical)WorkplaceVaccine hesitancyVaccines
researchProduct

Initiation of adaptive immune responses by transcutaneous immunization.

2007

The development of new, effective, easy-to-use and lower-cost vaccination approaches for the combat against malignant and infectious diseases is a pre-eminent need: cancer is a leading cause of morbidity in the Western World; there are numerous pathogenic diseases for which we still have no protective or therapeutic cure; and the financial limitations of developing countries to fight these diseases. In this mini-review we focus on transcutaneous immunization (TCI), a relatively new route for antigen delivery. TCI protocols appear to be particularly promising by gaining access to skin resident APC, which are highly efficient for the initiation of humoral and/or cellular immune responses. Con…

Vaccinesbiologymedicine.medical_treatmentImmunologyReverse vaccinologyReceptors Lymphocyte HomingTLR7Major histocompatibility complexAdministration CutaneousEpitopeVaccinationImmune systemImmunity ActiveAntigenImmunologymedicinebiology.proteinImmunology and AllergyAnimalsHumansImmunizationAdjuvantImmunology letters
researchProduct

Vaccines Through Centuries: Major Cornerstones of Global Health

2015

Multiple cornerstones have shaped the history of vaccines, which may contain live-attenuated viruses, inactivated organisms/viruses, inactivated toxins, or merely segments of the pathogen that could elicit an immune response. The story began with Hippocrates 400 B.C. with his description of mumps and diphtheria. No further discoveries were recorded until 1100 A.D. when the smallpox vaccine was described. During the eighteenth century, vaccines for cholera and yellow fever were reported and Edward Jenner, the father of vaccination and immunology, published his work on smallpox. The nineteenth century was a major landmark, with the "Germ Theory of disease" of Louis Pasteur, the discovery of t…

Vaccinesbusiness.industryViral VaccineDiphtherialcsh:Public aspects of medicineVaccine controversiesVaccinationhistory of vaccinesPublic Health Environmental and Occupational Healthglobal healthlcsh:RA1-1270Reviewmedicine.diseaseVirologyhumanitiesVaccinationImmunizationmedicinePertussis vaccineSmallpoxImmunizationPublic HealthbusinessSmallpox vaccinemedicine.drugFrontiers in Public Health
researchProduct

A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra: immunogenicity and safety profile

2009

Abstract Priorix-Tetra ™ (GlaxoSmithKline Biologicals) is a combined measles, mumps, rubella and varicella (MMRV) vaccine. Eight studies involving more than 3000 children were reviewed. Compared with co-administration of MMR ( Priorix ™) and varicella ( Varilrix ™) vaccines, the MMRV vaccine showed: similar immunogenicity, with immunity shown up to 3 years post-vaccination; a higher rate of fever after the first dose; a slight increase in mild local reactions after the second dose. This MMRV vaccine can be used either as a two-dose vaccine or as a second dose in children primed with separate MMR and/or varicella vaccines, offering a convenient way to introduce varicella vaccination into rou…

Varicella vaccineImmunization Secondarymedicine.vaccineAntibodies ViralRubellaMeaslesChickenpox VaccinemedicineHumansVaccines CombinedChildClinical Trials as TopicReactogenicityMMRV vaccineGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryImmunogenicityPublic Health Environmental and Occupational HealthInfantvirus diseasesmedicine.diseaseVirologyVaccinationInfectious DiseasesImmunizationChild PreschoolMolecular MedicinebusinessMeasles-Mumps-Rubella Vaccine
researchProduct

MMR and MMRV vaccines.

2018

Measles, mumps, rubella and varicella are viral infections which can implicate seriously long-term sequelae of infected individuals or even the unborn child. Vaccines against the individual diseases have long been available. Global measles vaccination is estimated to have prevented more than 20million deaths during 2000-2015. During the same time period, measles incidence decreased from 146 to 36 cases per million populations. Today vaccinations against measles, mumps, rubella and varicella are now carried out mainly with combination vaccines. These are today known as immunogenic and safe. MMRV had similar immunogenicity and overall safety profiles to MMR administered with or without varice…

Varicella vaccineRubellaMeasles03 medical and health sciences0302 clinical medicineChickenpox030225 pediatricsmedicineHumans030212 general & internal medicineAdverse effectMumpsRubellaVaccinesGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryImmunogenicityIncidence (epidemiology)VaccinationPublic Health Environmental and Occupational Healthvirus diseasesmedicine.diseaseVaccinationInfectious DiseasesImmunizationImmunologyMolecular MedicinebusinessMeaslesVaccine
researchProduct

Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us – and what they don't

2021

In the present issue of the Journal [1], Smadja et al. present an analysis of global pharmacovigilance reports of thrombotic events following severe acute respiratory distress syndrome coronavirus (SARS-CoV)-2 vaccination. More specifically, the authors analysed the data entered into the World Health Organization (WHO) Global Database for Individual Case Safety Reports (VigiBase) between December 13, 2020 and March 16, 2021, covering, at that time, a population of almost 362 million vaccinated individuals across the world. The study focuses on three of the coronavirus disease (COVID)-19 vaccines available to date, namely the Pfizer-BioNtech (BNT162b2), Moderna (mRNA-1273), and OxfordAstraZe…

Venous ThrombosisPulmonary and Respiratory Medicine2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationCOVID-19ThrombosisVaccination03 medical and health sciencesEditorial0302 clinical medicine030228 respiratory systemPharmacovigilancemedicineHumans030212 general & internal medicineIntensive care medicinebusinessThrombotic complicationEuropean Respiratory Journal
researchProduct